Biotech News
Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
investors.beamtx.com2026-05-06 14:46 EST
CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, will present at the 44 th Annual J.P.